Inside The World of Cell Therapies

While uptake has been limited, cell therapy’s impact in cancer care is growing, and biotech companies have continued to invest in ways to improve it, such as through “off-the-shelf” options or by using different types of immune cells. Explore the current market for cancer cell therapies and what biotechs are working on next.

INCLUDED IN THIS TRENDLINE

  • A new biotech wants to ease a bottleneck in cell and gene therapy production
  • Bristol Myers boosts cell therapy production with Novartis plant
  • Cancer drug startup Cargo raises $200M to solve CAR-T relapse

Request Free!